Enzyme replacement and enhancement therapies: Lessons from lysosomal disorders

被引：210

作者：

Desnick, RJ ^{[1
]}

Schuchman, EH ^{[1
]}

机构：

[1] NYU, Mt Sinai Sch Med, Dept Human Genet, New York, NY 10029 USA

来源：

NATURE REVIEWS GENETICS | 2002年 / 3卷 / 12期

基金：

美国国家卫生研究院;

关键词：

D O I：

10.1038/nrg963

中图分类号：

Q3 [遗传学];

学科分类号：

071007 ; 090102 ;

摘要：

The past decade has witnessed remarkable advances in our ability to treat inherited metabolic disorders, especially the lysosomal storage diseases, a group of more than 40 disorders, each of which is caused by the deficiency of a lysosomal enzyme or protein. During the past few years, both enzyme replacement and enhancement therapies have been developed to treat these disorders. This review discusses the successes and shortcomings of these therapeutic strategies, and the contributions that they have made to treating lysosomal storage diseases.

引用

页码：954 / 966

页数：13

共 114 条

[81] ACID SPHINGOMYELINASE-DEFICIENT MICE MIMIC THE NEUROVISCERAL FORM OF HUMAN LYSOSOMAL STORAGE DISEASE (NIEMANN-PICK DISEASE)
OTTERBACH, B
STOFFEL, W
[J]. CELL, 1995, 81 (07) : 1053 - 1061
[82] Platt FM, 1998, BIOCHEM PHARMACOL, V56, P421
[83] CORRECTION OF ABNORMAL CEREBROSIDE SULFATE METABOLISM IN CULTURED METACHROMATIC LEUKODYSTROPHY FIBROBLASTS
PORTER, MT
FLUHARTY, AL
KIHARA, H
[J]. SCIENCE, 1971, 172 (3989) : 1263 - &
[84] Targeted disruption of the acid α-glucosidase gene in mice causes an illness with critical features of both infantile and adult human glycogen storage disease type II
Raben, N
Nagaraju, K
Lee, E
Kessler, P
Byrne, B
Lee, L
LaMarca, M
King, C
Ward, J
Sauer, B
Plotz, P
[J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 1998, 273 (30) : 19086 - 19092
[85] RATTAZZI MC, 1991, TREATMENT GENETIC DI, P131
[86] In vitro pharmacologic restoration of CFTR-mediated chloride transport with sodium 4-phenylbutyrate in cystic fibrosis epithelial cells containing Delta F508-CFTR
Rubenstein, RC
Egan, ME
Zeitlin, PL
[J]. JOURNAL OF CLINICAL INVESTIGATION, 1997, 100 (10) : 2457 - 2465
[87] SABATINI DD, 2001, METABOLIC MOL BASES, P475
[88] CHARACTERIZATION OF A MEMBRANE-ASSOCIATED RECEPTOR FROM BOVINE LIVER THAT BINDS PHOSPHOMANNOSYL RESIDUES OF BOVINE TESTICULAR BETA-GALACTOSIDASE
SAHAGIAN, GG
DISTLER, J
JOURDIAN, GW
[J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA-BIOLOGICAL SCIENCES, 1981, 78 (07): : 4289 - 4293
[89] Biodistribution, kinetics, and efficacy of highly phosphorylated and non-phosphorylated β-glucuronidase in the murine model of mucopolysaccharidosis VII
Sands, MS
Vogler, CA
Ohlemiller, KK
Roberts, MS
Grubb, JH
Levy, B
Sly, WS
[J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2001, 276 (46) : 43160 - 43165
[90] MOUSE MODELS OF TAY-SACHS AND SANDHOFF DISEASES DIFFER IN NEUROLOGIC PHENOTYPE AND GANGLIOSIDE METABOLISM
SANGO, K
YAMANAKA, S
HOFFMANN, A
OKUDA, Y
GRINBERG, A
WESTPHAL, H
MCDONALD, MP
CRAWLEY, JN
SANDHOFF, K
SUZUKI, K
PROIA, RL
[J]. NATURE GENETICS, 1995, 11 (02) : 170 - 176

← 3 4 5 6 7 8 9 10 11 12 →